Back to Search
Start Over
Eculizumab cessation in atypical hemolytic uremic syndrome.
- Source :
-
Blood [Blood] 2017 Jul 20; Vol. 130 (3), pp. 368-372. Date of Electronic Publication: 2017 May 01. - Publication Year :
- 2017
- Subjects :
- Antibodies, Monoclonal, Humanized administration & dosage
Antibodies, Monoclonal, Humanized economics
Atypical Hemolytic Uremic Syndrome economics
Atypical Hemolytic Uremic Syndrome therapy
Drug Administration Schedule
Drug Costs
Female
Follow-Up Studies
Humans
Male
Middle Aged
Recurrence
Renal Dialysis statistics & numerical data
Retrospective Studies
Antibodies, Monoclonal, Humanized therapeutic use
Atypical Hemolytic Uremic Syndrome drug therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1528-0020
- Volume :
- 130
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Blood
- Publication Type :
- Report
- Accession number :
- 28461395
- Full Text :
- https://doi.org/10.1182/blood-2017-02-770214